{"id":453955,"date":"2021-03-09T11:03:13","date_gmt":"2021-03-09T16:03:13","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=453955"},"modified":"2021-03-09T11:03:13","modified_gmt":"2021-03-09T16:03:13","slug":"wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/","title":{"rendered":"WATS3D Receives Medically Necessary Designation from\u00a0Blue Cross Blue Shield of Kansas City"},"content":{"rendered":"<h2>\nKansas City joins Hawaii Medical Services Association, BCBS South Carolina,\u00a0and Avalon in considering WATS3D a covered benefit<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">SUFFERN, N.Y., March  09, 2021  (GLOBE NEWSWIRE) &#8212; WATS<sup>3D<\/sup>, a diagnostic platform used by physicians to detect Barrett\u2019s esophagus (BE), pre-cancer and cancerous cells in the esophagus, has received a positive medically necessary designation from Blue Cross Blue Shield (BCBS) of Kansas City. The technology, developed by CDx Diagnostics and clinically proven to significantly increase the detection rate of both BE and esophageal dysplasia compared to the traditional screening methods, is now a covered benefit for BCBS Kansas City\u2019s 611,000 members across Kansas and Missouri.<\/p>\n<p>This marks the fifth organization to add a WATS<sup>3D<\/sup> to their benefits in the last quarter. Members of BCBS Kansas City, Hawaii Medical Services Association (HMSA), BCBS South Carolina, and Avalon, now have access to the American Society for Gastrointestinal Endoscopy (ASGE) Guideline approved technology. \u201cWe\u2019re excited to strengthen our medical policy status within the Blue Cross Blue Shield network with the addition of Kansas City,\u201d says CDx Diagnostics CEO Bill Huffnagle. \u201cThe advocacy from referring physicians and endorsements from foremost medical societies has been instrumental in building the awareness within the payer community. Most importantly, over 600,000 individuals in the Kansas City market now have access to this potentially life-saving technology.\u201d<\/p>\n<p>WATS<sup>3D<\/sup> overcomes the limitations associated with traditional upper endoscopy screening and surveillance methods through the use of a unique combination of superior sampling, advanced 3D imaging, and Artificial Intelligence analysis to reliably detect BE and esophageal dysplasia. The technology has received recognition for completing the five major pillars of evidence-based medicine, including Analytic Validity, Clinical Validity, Clinical Utility, Cost Effectiveness and Recommendations by Major Medical Societies, including the American Society for Gastrointestinal Endoscopy (ASGE), the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and the American Foregut Society (AFS).<\/p>\n<p>In 2019, the ASGE included WATS<sup>3D<\/sup> in its Standards of Practice Committee\u2019s guideline for the screening and surveillance of BE. In 2020, the technology was deemed a safe and effective adjunct to forceps biopsies in the evaluation of BE, low-grade dysplasia, and high-grade dysplasia by SAGES and its Technology and Value Assessment Committee (TAVAC).<\/p>\n<p>\n        <strong>About CDx Diagnostics<\/strong><br \/>\n        <br \/>CDx Diagnostics\u2019 mission of <em>Empowering Physicians With Innovative Technology To Prevent Esophageal Cancer<\/em>, <em>One Patient at a Time<\/em> is accomplished by a proprietary diagnostic platform that synthesizes computer imaging, artificial intelligence, molecular biology and three-dimensional cytopathology to detect precancerous change earlier and more reliably than prior methods. CDx tests require only a few minutes of practice time, are highly cost effective, widely reimbursed, and address a recognized critical gap in the current diagnostic standard of care that results in thousands of otherwise unnecessary cancer deaths each year. Routine clinical use of CDx testing has already detected thousands of cancers that would otherwise have been missed in time for effective endoscopic treatment and application of the CDx Diagnostics platform to prevent cancers of the bile duct, stomach, and IBD affected colon is currently in progress. CDx Diagnostics is a Galen Partners portfolio company. To learn more, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-87yPx2Ga--nhHD0WfxLPmCi7LgfQkp_P_29Oyiyrq4NaV8TGnwxz27eJrMBQuDwH1u_okruZnZEx4hCO-waeu-e4O-iErHAceBkiYG4tr0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/www.cdxdiagnostics.com<\/a>.<\/p>\n<p>Contact: Donnie Turlington<br \/>Phone: 336-991-7711<\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzAxMyM0MDU1NDUzIzIxOTcyODg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/f8c9ac3b-6fc1-4039-b555-2a239fee7764\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Kansas City joins Hawaii Medical Services Association, BCBS South Carolina,\u00a0and Avalon in considering WATS3D a covered benefit SUFFERN, N.Y., March 09, 2021 (GLOBE NEWSWIRE) &#8212; WATS3D, a diagnostic platform used by physicians to detect Barrett\u2019s esophagus (BE), pre-cancer and cancerous cells in the esophagus, has received a positive medically necessary designation from Blue Cross Blue Shield (BCBS) of Kansas City. The technology, developed by CDx Diagnostics and clinically proven to significantly increase the detection rate of both BE and esophageal dysplasia compared to the traditional screening methods, is now a covered benefit for BCBS Kansas City\u2019s 611,000 members across Kansas and Missouri. This marks the fifth organization to add a WATS3D to their benefits in the last quarter. Members of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;WATS3D Receives Medically Necessary Designation from\u00a0Blue Cross Blue Shield of Kansas City&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-453955","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>WATS3D Receives Medically Necessary Designation from\u00a0Blue Cross Blue Shield of Kansas City - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WATS3D Receives Medically Necessary Designation from\u00a0Blue Cross Blue Shield of Kansas City - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Kansas City joins Hawaii Medical Services Association, BCBS South Carolina,\u00a0and Avalon in considering WATS3D a covered benefit SUFFERN, N.Y., March 09, 2021 (GLOBE NEWSWIRE) &#8212; WATS3D, a diagnostic platform used by physicians to detect Barrett\u2019s esophagus (BE), pre-cancer and cancerous cells in the esophagus, has received a positive medically necessary designation from Blue Cross Blue Shield (BCBS) of Kansas City. The technology, developed by CDx Diagnostics and clinically proven to significantly increase the detection rate of both BE and esophageal dysplasia compared to the traditional screening methods, is now a covered benefit for BCBS Kansas City\u2019s 611,000 members across Kansas and Missouri. This marks the fifth organization to add a WATS3D to their benefits in the last quarter. Members of &hellip; Continue reading &quot;WATS3D Receives Medically Necessary Designation from\u00a0Blue Cross Blue Shield of Kansas City&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-09T16:03:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzAxMyM0MDU1NDUzIzIxOTcyODg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"WATS3D Receives Medically Necessary Designation from\u00a0Blue Cross Blue Shield of Kansas City\",\"datePublished\":\"2021-03-09T16:03:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\\\/\"},\"wordCount\":534,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzAxMyM0MDU1NDUzIzIxOTcyODg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\\\/\",\"name\":\"WATS3D Receives Medically Necessary Designation from\u00a0Blue Cross Blue Shield of Kansas City - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzAxMyM0MDU1NDUzIzIxOTcyODg=\",\"datePublished\":\"2021-03-09T16:03:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzAxMyM0MDU1NDUzIzIxOTcyODg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzAxMyM0MDU1NDUzIzIxOTcyODg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"WATS3D Receives Medically Necessary Designation from\u00a0Blue Cross Blue Shield of Kansas City\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"WATS3D Receives Medically Necessary Designation from\u00a0Blue Cross Blue Shield of Kansas City - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/","og_locale":"en_US","og_type":"article","og_title":"WATS3D Receives Medically Necessary Designation from\u00a0Blue Cross Blue Shield of Kansas City - Market Newsdesk","og_description":"Kansas City joins Hawaii Medical Services Association, BCBS South Carolina,\u00a0and Avalon in considering WATS3D a covered benefit SUFFERN, N.Y., March 09, 2021 (GLOBE NEWSWIRE) &#8212; WATS3D, a diagnostic platform used by physicians to detect Barrett\u2019s esophagus (BE), pre-cancer and cancerous cells in the esophagus, has received a positive medically necessary designation from Blue Cross Blue Shield (BCBS) of Kansas City. The technology, developed by CDx Diagnostics and clinically proven to significantly increase the detection rate of both BE and esophageal dysplasia compared to the traditional screening methods, is now a covered benefit for BCBS Kansas City\u2019s 611,000 members across Kansas and Missouri. This marks the fifth organization to add a WATS3D to their benefits in the last quarter. Members of &hellip; Continue reading \"WATS3D Receives Medically Necessary Designation from\u00a0Blue Cross Blue Shield of Kansas City\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-09T16:03:13+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzAxMyM0MDU1NDUzIzIxOTcyODg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"WATS3D Receives Medically Necessary Designation from\u00a0Blue Cross Blue Shield of Kansas City","datePublished":"2021-03-09T16:03:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/"},"wordCount":534,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzAxMyM0MDU1NDUzIzIxOTcyODg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/","name":"WATS3D Receives Medically Necessary Designation from\u00a0Blue Cross Blue Shield of Kansas City - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzAxMyM0MDU1NDUzIzIxOTcyODg=","datePublished":"2021-03-09T16:03:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzAxMyM0MDU1NDUzIzIxOTcyODg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzAxMyM0MDU1NDUzIzIxOTcyODg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/wats3d-receives-medically-necessary-designation-from-blue-cross-blue-shield-of-kansas-city\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"WATS3D Receives Medically Necessary Designation from\u00a0Blue Cross Blue Shield of Kansas City"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/453955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=453955"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/453955\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=453955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=453955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=453955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}